You are here : ERS ASSEMBLIES Cell and Molecular Biology

Cell and Molecular Biology

Head: Thomas Geiser
Secretary: Bruno Crestani

This Assembly provides the necessary forum for interaction between basic scientists and practicing clinicians interested in the cellular and molecular mechanisms involved within the healthy and diseased lung. It is also responsible for tracking scientific developments that easily translate into better diagnostic technologies and/or enhanced patient care. This has allowed collaborative forums with the other clinical Assemblies of the ERS.

  • Molecular Pathology and Functional Genomics

    Chair: Philipp A. Schnabel
    Secretary: Marcin Skrzypski

    The objectives of this Group are to make progress in the understanding of  various mechanisms involved in lung biology (including lung development) and lung pathophysiology. Its organisation is dedicated to bringing together basic research and clinical investigation.

    Read more...

  • Airway Cell Biology and Immunopathology

    Chair: Catherine Greene
    Secretary: Clifford Taggart

    The cells that constitute the airway wall and line the airways have an important role in many different diseases, such as asthma, cancer or pneumonia. They are central elements in innate and adaptive immunity, carcinogenesis and remodeling of the airway wall. This Group aims to offer a platform for scientists studying the cell and molecular biology of these cells in health, disease and development. Such integrated research efforts are considered essential to ultimately decrease morbidity and mortality from respiratory disorders. Read more...

  • Mechanisms of Lung Injury and Repair

    Chair: Stefan Uhlig
    Secretary: Martin Kolb


    The lung injury section of this Assembly brings together members who are interested in the cellular and molecular basis of injury to the lungs and new approaches to treatment for lung injury. Its members are interested in the mechanisms of disease related to acute lung injury (e.g. ARDS), fibrotic reactions, injury created by host-pathogen interactions, drug-induced lung injury and other mechanisms of acute and chronic lung injury, and includes clinicians, clinician/investigators and basic scientists who share these common interests.

    Read more...

 

Share facebook Share linkedIn Share twitter
Share rss